Teva Pharmaceutical Industries Ltd TEVJF:OTCPK

RT Quote | Exchange | USD
Last | 05/26/22 EDT
9.04UNCH (UNCH)
52 week range
7.20 - 11.23
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close9.04
  • 52 Week High11.23
  • 52 Week High Date06/10/21
  • 52 Week Low7.20
  • 52 Week Low Date03/07/22

Key Stats

  • Market Cap9,317.23M
  • Shares Out1,110.35M
  • 10 Day Average Volume9,556.33
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change4.51

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close9.04
  • 52 Week High11.23
  • 52 Week High Date06/10/21
  • 52 Week Low7.20
  • 52 Week Low Date03/07/22
  • Market Cap9,317.23M
  • Shares Out1,110.35M
  • 10 Day Average Volume9,556.33
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change4.51

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date11/24/2017
  • Div Amount0.298
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract...
Sol Barer Ph.D.
Independent Chairman of the Board
Kaare Schultz
President, Chief Executive Officer, Director
Eliyahu Kalif
Chief Financial Officer, Executive Vice President
David Stark
Executive Vice President, Chief Legal Officer
Sven Dethlefs Ph.D.
Executive Vice President - North America Commercial
Address
5 Bazel St, P O B 3190
Petah Tikva
49131
Israel